Stay updated on Efpeglenatide Cardiovascular Outcomes Clinical Trial
Sign up to get notified when there's something new on the Efpeglenatide Cardiovascular Outcomes Clinical Trial page.

Latest updates to the Efpeglenatide Cardiovascular Outcomes Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added to the history and the funding-status notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide funding notice was added, and the revision tag was updated from v3.4.0 to v3.4.1. No study record content, status, or data appears to be changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedUI/record history page updates include a glossary display option, new color-coding highlights for additions and deletions, and updated revision/version text. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check42 days agoChange DetectedThe page history now includes a new revision entry v3.3.4 and removes the previous revision v3.3.3.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a new history revision entry (Revision: v3.3.3) to the page history and removed the HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer, which are minor navigation/version-tracking updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page history now includes a new revision (v3.3.2) and removes an older one (v3.2.0), indicating a minor update to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Efpeglenatide Cardiovascular Outcomes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efpeglenatide Cardiovascular Outcomes Clinical Trial page.